XM does not provide services to residents of the United States of America.

XM does not provide services to residents of the United States of America.
A
A

Amgen

News

Reuters - 20 hours ago

Wall Street awaits Amgen weight-loss drug data expected to move shares

ANALYSIS-Wall Street awaits Amgen weight-loss drug data expected to move shares Amgen's MariTide aims for quicker weight loss, fewer doses than GLP-1 drugs Analysts expect MariTide to show at least 20% weight loss Concerns over side effects, including nausea and bone density issues By Deena Beasley Nov 21 (Reuters) - Upcoming data from a mid-stage study of Amgen's AMGN.O experimental weight-loss drug MariTide will shed light on how well it might measure up against the popular GLP-1 drugs sold by
A
Reuters - 3 days ago

Lilly pill cuts genetic form of cholesterol nearly 86% in study

Lilly pill cuts genetic form of cholesterol nearly 86% in study By Julie Steenhuysen CHICAGO, Nov 18 (Reuters) - The highest dose of an experimental pill developed by Eli Lilly LLY.N dramatically lowered an inherited form of high cholesterol in a mid-stage trial, according to data presented at a medical meeting on Monday. The drug, muvalaplin, reduced levels of lipoprotein(a), or Lp(a), by 70% using a traditional blood test and by nearly 86% based on a more specific test developed by the company
A
N
Reuters - 4 days ago

Wall St indexes mixed; Nvidia earnings, Fed policy in focus

US STOCKS-Wall St indexes mixed; Nvidia earnings, Fed policy in focus For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Nvidia falls after report Blackwell chips overheating Tesla jumps after report Trump team's could ease rules CVS Health gains on new board appointments in Glenview deal Indexes: Dow down 0.08%, S&P 500 up 0.10%, Nasdaq up 0.24% Updated at 09:43 a.m.
A
A
G
N
U
U
L
Reuters - 1 week ago

Drugmakers extend declines after Trump picks RFK Jr to lead top US health agency

BUZZ-Drugmakers extend declines after Trump picks RFK Jr to lead top US health agency Updates ** Shares of vaccine makers extend declines after President-elect Donald Trump selected Robert F. Kennedy Jr to lead the Department of Health and Human Services, the United States' top health agency ** U.S.-listed shares of BioNTech 22UAy.DE , BNTX.O down ~5% to $98.41, Moderna MRNA.O falls 5.20% to $37.50, Novavax NVAX.O down ~3% at $7, while Pfizer PFE.N down 4.05% at $24.97 ** Kennedy has frequently
A
J
P
Reuters - 1 week ago

U.S. STOCKS Talen Energy, Biogen, Ovintiv

BUZZ-U.S. STOCKS ON THE MOVE-Talen Energy, Biogen, Ovintiv Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were subdued on Thursday after monthly producer prices rose as expected, with investors awaiting Fed Chair Jerome Powell's comments later in the day for clues on the outlook for interest rates.
A
A
B
C
N
W
U
U
A
H
Reuters - 1 week ago

U.S. STOCKS Oklo, Adial Pharma, Sonos

BUZZ-U.S. STOCKS ON THE MOVE-Oklo, Adial Pharma, Sonos Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes edged lower in choppy trading on Thursday after monthly producer prices rose as expected, with investors awaiting Fed Chair Jerome Powell's comments later in the day for clues on the outlook for interest rates.
A
C
N
A
U
U
A
Reuters - 1 week ago

Citi starts coverage on Amgen with 'neutral' on caution over obesity drug

BUZZ-Citi starts coverage on Amgen with 'neutral' on caution over obesity drug ** Citi Research starts coverage on Amgen AMGN.O with a "neutral" rating, citing risks to co's experimental weight-loss drug, MariTide, due to intense competition ** Brokerage sets a PT of $335, representing an ~11% upside to stock's last closing price ** Citi says Clini
A
Reuters - 1 week ago

U.S. Cisco, Freshpet, Nvidia

U.S. RESEARCH ROUNDUP-Cisco, Freshpet, Nvidia Nov 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cisco, Freshpet and Nvidia, on Thursday. HIGHLIGHTS * Cisco CSCO.O : Jefferies raises target price to $66 from $53 * Freshpet Inc FRPT.O : Oppenheimer raises target price to $180 from $155 * ICU Medical Inc ICUI.O : Raymond James raises target price to $205 from $190 * Kronos Bio Inc KRON.O : TD Cowen cuts to hold fro
A
A
B
C
N
A
A
A
Reuters - 1 week ago

Amgen "Laser Focused" On A Phase 3 Development Program For Its Obesity Drug MariTide

BRIEF-Amgen "Laser Focused" On A Phase 3 Development Program For Its Obesity Drug MariTide Nov 13 (Reuters) - Amgen Inc AMGN.O : AMGEN EXEC SAYS CO CONTINUES TO BE "LASER FOCUSED" ON A PHASE THREE DEVELOPMENT PROGRAM FOR ITS OBESITY DRUG MARITIDE - UBS HEALTHCARE CONFERENCE AMGEN EXEC SAYS CO HAS NOT SEEN ANY ASSOCIATION BETWEEN ADMINISTRATION OF M
A
Reuters - 1 week ago

U.S. STOCKS BankUnited, Natera, Adaptimmune

BUZZ-U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes inched higher on Wednesday after in-line consumer price inflation data kept the U.S. Federal Reserve on track to deliver another interest rate cut in December.
A
B
S
T
K
U
U
S
Reuters - 1 week ago

Wall St set for higher open as inflation data keeps Fed rate-cut hopes intact

US STOCKS-Wall St set for higher open as inflation data keeps Fed rate-cut hopes intact For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window CPI rises 0.2% in October as forecast Amgen gains after dismissing concerns related to its new weight-loss drug Rivian soars after Volkswagen increases investment Spirit Airlines plummets after report says preparing for bankruptcy filing Futures up: Dow 0.12%, S&P 500 0.17%, Nasdaq 0.12% Updated at 8:47
A
P
T
V
U
U
U
Reuters - 1 week ago

U.S. STOCKS Rivian, Amgen, Cava

BUZZ-U.S. STOCKS ON THE MOVE-Rivian, Amgen, Cava Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures turned positive on Wednesday after an in-line reading of the consumer price index did little to change expectations for the Federal Reserve's monetary policy path.
A
S
T
S
Reuters - 1 week ago

Futures dip as focus shifts to inflation data for clues on Fed's rate path

US STOCKS-Futures dip as focus shifts to inflation data for clues on Fed's rate path For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Amgen gains after dismissing concerns related to its new weight-loss drug Rivian soars after Volkswagen increases investment Spirit Airlines plummets after report says preparing for bankruptcy filing Futures down: Dow 0.29%, S&P 500 0.21%, Nasdaq 0.24% Updated at 07:18 a.m.
A
M
P
T
V
U
U
U
Reuters - 1 week ago

U.S. STOCKS Rivian, Amgen, Cava

BUZZ-U.S. STOCKS ON THE MOVE-Rivian, Amgen, Cava Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures edged lower on Wednesday as an uptick in Treasury yields weighed on rate-sensitive equities ahead of crucial inflation data that will offer more signals on the pace of the Federal Reserve's interest rate reductions.
A
S
S
Reuters - 1 week ago

Street View: Concerns over Amgen's weight-loss drug are overblown

BUZZ-Street View: Concerns over Amgen's weight-loss drug are overblown ** Amgen AMGN.O said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density , a day after concerns highlighted in a brokerage report wiped more than $12 billion off the company's market value ** Analysts at Cantor Fitzgerald said on
A
Reuters - 1 week ago

Futures slip as markets await inflation data for clues on Fed's rate path

US STOCKS-Futures slip as markets await inflation data for clues on Fed's rate path For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Futures down: Dow 0.14%, S&P 500 0.14%, Nasdaq 0.13% Nov 13 (Reuters) - U.S. stock index futures edged lower on Wednesday as an uptick in Treasury yields weighed on rate-sensitive equities ahead of crucial inflation data that will offer more signals on the pace of the Federal Reserve's interest rate reductio
A
M
P
T
V
U
U
U
Reuters - 1 week ago

Amgen dismisses bone density concerns related to its weight-loss drug

UPDATE 5-Amgen dismisses bone density concerns related to its weight-loss drug Cantor analysts cited early data suggesting bone safety risk Amgen confident in drug's profile, plans to release mid-stage study data later this year Amgen shares partially recover after a 7% decline in previous session Adds comments from company executive in paragraphs 4 and 9 By Leroy Leo and Bhanvi Satija Nov 13 (Reuters) - Amgen AMGN.O said on Wednesday there was no link between its experimental weight-loss drug a
A
Reuters - 1 week ago

Amgen sees no bone safety concerns around experimental obesity drug

Amgen sees no bone safety concerns around experimental obesity drug Nov 13 (Reuters) - Amgen AMGN.O said on Wednesday it does not see any bone safety concerns around the use of its experimental obesity drug, a day after data from an early-stage study dragged its stock 7% lower. Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli
A
Reuters - 1 week ago

Wall Street indexes dip with focus on Trump policies, economic data

US STOCKS-Wall Street indexes dip with focus on Trump policies, economic data Novavax drops 6% on cut to annual revenue forecast Honeywell jumps to record high as Elliott discloses stake Tesla ends 5-day rally with 6% drop Indexes down: Dow 0.86%, S&P 500 0.29%, Nasdaq 0.09% Updates with final prices, volume data By Sinéad Carew and Lisa Pauline Mattackal Nov 12 (Reuters) - Wall Street's three major indexes closed lower on Tuesday as investors booked some profits from a post-election rally and
A
T
U
U
Reuters - 1 week ago

Amgen's obesity drug data shows bone mineral density loss, say Cantor

BUZZ-Amgen's obesity drug data shows bone mineral density loss, say Cantor ** Brokerage Cantor Fitzgerald says Amgen's experimental obesity drug MariTide showed a 4% bone mineral density loss in an early-stage trial data , that was published in February ** Cantor says the data was a "big unknown" and "risk" given the drug's mechanism; says the info
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.